Trails Edge Capital Partners, LP

CIK

2077247

Location

ATLANTA, GA

Portfolio Value

Small $629,911,875

Diversification

Diversified

Filing Date

Global Rank

#3,345 / 8,825 ▲ 519

Top Industry

Biotechnology 99.2%

3Y Alpha vs SPY

+1.3%

Period ended 4 months ago

Filed Aug 14, 2026 · 3mo

3 quarters · since Dec 2025

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Unknown

Schedule 13D/13G stakes

Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.

Company	Schedule	Event date	Filed	Shares	% of class	Change	Status
AVTX Avalo Therapeutics, Inc.	13G	Oct 22, 2026	6d	2,803,761	5.2%	—	Current
SLGL Sol-Gel Technologies Ltd.	13G	Oct 20, 2026	8d	166,473	5.1%	—	Current
CTNM Contineum Therapeutics, Inc.	13G	Sep 22, 2026	13d	1,679,443	5.1%	—	Current
CAMP Camp4 Therapeutics Corp	13G	Aug 3, 2026	3mo	3,790,636	6%	—	Current
RACD Research Alliance Corp IV	13G	Jul 14, 2026	4mo	500,000	5.5%	—	Current
RACC Research Alliance Corp III	13G	May 21, 2026	5mo	500,000	5.5%	—	Current
IMA ImageneBio, Inc.	13G	Apr 14, 2026	7mo	1,176,472	9.9%	—	Current
IKT Inhibikase Therapeutics, Inc.	13G/A	Mar 31, 2026	6mo	8,057,345	6.1%	+1,912,147 since Dec 23, 2025	Current
OKUR OnKure Therapeutics, Inc.	13G	Mar 31, 2026	7mo	2,409,638	6%	—	Current
IMUX Immunic, Inc.	13G	Feb 17, 2026	8mo	1,145,400	8.7%	—	Current
PMN ProMIS Neurosciences Inc.	13G	Feb 3, 2026	9mo	933,477	9.9%	—	Current
XFOR X4 Pharmaceuticals, Inc	13G/A	Dec 31, 2025	9mo	5,227,222	5.8%	+2,910,069 since Aug 11, 2025	Current
LBRX Lb Pharmaceuticals Inc	13G	Dec 24, 2025	10mo	1,268,265	5%	—	Current
VTVT vTv Therapeutics Inc.	13G	Aug 29, 2025	1y	340,536	9.9%	—	Current

A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis. Show 3 exited, below-5% or retired stakes

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Diversified active

Top 10 weight 50.3%, 25.6 effective positions, active share 98.9% against the Russell 2000 as of 2026-06-30; it meets none of the index-like, systematic-like or concentrated tests

Turnover

Turnover unknown

It needs four straight quarters of measured turnover

Horizon

Short horizon

Value-weighted holding period 2.1 quarters (under 4)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 98.9%; sector active share 90.1% against the combined 13F book's sector weights.

Over time 3 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

35 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

7.8%

−1.0 pts

Top 5

28.8%

−10.6 pts

Top 10

50.3%

−15.1 pts

HHI

391

Diversified−148

Portfolio Trend

3 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	99.2%	$624,561,875	34
Financial Services	0.8%	$5,350,000	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

10 positions

Ticker	Company	Δ Shares	Shares	Value
IRD	Opus Genetics, Inc.	+2,243,658	2,743,658	$11,276,434
IPSC	Century Therapeutics, Inc.	+1,684,976	4,134,969	$10,130,674
DSGN	Design Therapeutics, Inc.	+1,149,269	2,001,282	$28,958,550
IKT	Inhibikase Therapeutics, Inc.	+993,973	9,051,318	$18,374,175
FDMT	4D Molecular Therapeutics, Inc.	+925,000	2,227,917	$29,631,296
SNDX	Syndax Pharmaceuticals Inc	+408,179	1,110,000	$24,264,600
FTH	Faeth Therapeutics, Inc.	+390,335	515,335	$12,883,375
IMCR	Immunocore Holdings plc	+380,637	1,063,234	$33,757,679
LBRX	Lb Pharmaceuticals Inc	+203,660	1,523,022	$49,429,679
SLGL	Sol-Gel Technologies Ltd.	+53,949	139,445	$10,338,452
No positions match the current search.

Trimmed

Positions the filer reduced

7 positions

Ticker	Company	Δ Shares	Shares	Value
NRIX	Nurix Therapeutics, Inc.	−170,000	1,573,220	$38,166,317
RVMD	Revolution Medicines, Inc.	−129,250	115,750	$21,677,660
MIRM	Mirum Pharmaceuticals, Inc.	−110,000	223,312	$26,143,135
NGNE	Neurogene Inc.	−67,902	714,885	$22,483,133
VTVT	vTv Therapeutics Inc.	−54,386	85,192	$3,207,478
CYTK	Cytokinetics Inc	−11,911	288,089	$24,542,301
CAMP	Camp4 Therapeutics Corp	−6,626	1,932,937	$8,446,934
No positions match the current search.

New Positions

Positions the filer opened this quarter

13 positions

Ticker	Company	Shares	Value
TRAX	First Tracks Biotherapeutics, Inc.	1,514,000	$30,461,680
BMRN	Biomarin Pharmaceutical Inc	512,000	$29,296,640
INSM	INSMED Inc	230,331	$24,557,891
KLRA	Kailera Therapeutics, Inc.	984,786	$21,694,835
INCY	Incyte Corp	155,000	$17,570,800
AVTX	Avalo Therapeutics, Inc.	891,881	$16,481,960
MLTX	MoonLake Immunotherapeutics	750,000	$14,602,500
AURA	Aura Biosciences, Inc.	1,443,333	$10,247,664
ALT	Altimmune, Inc.	2,660,000	$8,086,400
OKUR	OnKure Therapeutics, Inc.	1,438,456	$6,559,359
—		273,181	$5,805,096
RACC	Research Alliance Corp III	500,000	$5,350,000
IMA	ImageneBio, Inc.	282,004	$1,663,823
No positions match the current search.

Sold Out

Positions the filer fully exited

4 positions

Ticker	Company	Shares	Value
PCVX	Vaxcyte, Inc.	662,470	$38,496,131
DFTX	Definium Therapeutics, Inc.	1,738,110	$32,850,279
RCUS	Arcus Biosciences, Inc.	1,047,935	$22,635,396
IMVT	Immunovant, Inc.	414,054	$10,285,101
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

35 tracked positions · $629,911,875 total · filing declares 35 positions · $629,911,888 · as of Jun 30, 2026

All sectors Financial Services Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
LBRX	Lb Pharmaceuticals Inc Healthcare	Added	1,523,022	+203,660	$49,429,679	+51.9%	3	before history	7.85%
NRIX	Nurix Therapeutics, Inc. Healthcare	Reduced	1,573,220	-170,000	$38,166,317	+41.3%	3	before history	6.06%
IMCR	Immunocore Holdings plc Healthcare	Added	1,063,234	+380,637	$33,757,679	+64.0%	3	before history	5.36%
TRAX	First Tracks Biotherapeutics, Inc. Healthcare	NEW	1,514,000	NEW	$30,461,680	NEW	1	$18.70	4.84%
FDMT	4D Molecular Therapeutics, Inc. Healthcare	Added	2,227,917	+925,000	$29,631,296	+144.3%	2	$9.13	4.70%
BMRN	Biomarin Pharmaceutical Inc Healthcare	NEW	512,000	NEW	$29,296,640	NEW	1	$54.78	4.65%
DSGN	Design Therapeutics, Inc. Healthcare	Added	2,001,282	+1,149,269	$28,958,550	+219.4%	2	$11.47	4.60%
XENE	Xenon Pharmaceuticals Inc. Healthcare	Reduced	440,000	-200,000	$26,558,400	−28.6%	3	before history	4.22%
MIRM	Mirum Pharmaceuticals, Inc. Healthcare	Reduced	223,312	-110,000	$26,143,135	−15.1%	3	before history	4.15%
INSM	INSMED Inc Healthcare	NEW	230,331	NEW	$24,557,891	NEW	1	$121.09	3.90%
CYTK	Cytokinetics Inc Healthcare	Reduced	288,089	-11,911	$24,542,301	+24.1%	2	$63.55	3.90%
SNDX	Syndax Pharmaceuticals Inc Healthcare	Added	1,110,000	+408,179	$24,264,600	+48.0%	2	$21.39	3.85%
NGNE	Neurogene Inc. Healthcare	Reduced	714,885	-67,902	$22,483,133	+42.5%	3	before history	3.57%
KLRA	Kailera Therapeutics, Inc. Healthcare	NEW	984,786	NEW	$21,694,835	NEW	1	$21.98	3.44%
RVMD	Revolution Medicines, Inc. Healthcare	Reduced	115,750	-129,250	$21,677,660	−9.0%	2	$100.98	3.44%
IKT	Inhibikase Therapeutics, Inc. Healthcare	Added	9,051,318	+993,973	$18,374,175	+35.7%	3	before history	2.92%
INCY	Incyte Corp Healthcare	NEW	155,000	NEW	$17,570,800	NEW	1	$99.18	2.79%
AVTX	Avalo Therapeutics, Inc. Healthcare	NEW	891,881	NEW	$16,481,960	NEW	1	$15.81	2.62%
MLTX	MoonLake Immunotherapeutics Healthcare	NEW	750,000	NEW	$14,602,500	NEW	1	$18.13	2.32%
FTH	Faeth Therapeutics, Inc. Healthcare	Added	515,335	+390,335	$12,883,375	+227.0%	2	$22.37	2.05%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Held	2,571,478	0	$12,008,802	+13.1%	3	before history	1.91%
IRD	Opus Genetics, Inc. Healthcare	Added	2,743,658	+2,243,658	$11,276,434	+395.7%	2	$4.44	1.79%
SLGL	Sol-Gel Technologies Ltd. Healthcare	Added	139,445	+53,949	$10,338,452	+52.6%	2	$72.66	1.64%
AURA	Aura Biosciences, Inc. Healthcare	NEW	1,443,333	NEW	$10,247,664	NEW	1	$7.15	1.63%
IPSC	Century Therapeutics, Inc. Healthcare	Added	4,134,969	+1,684,976	$10,130,674	+83.0%	2	$2.18	1.61%
IVA	Inventiva S.A. Healthcare	Held	2,657,997	0	$10,047,228	−31.9%	3	before history	1.60%
CAMP	Camp4 Therapeutics Corp Healthcare	Reduced	1,932,937	-6,626	$8,446,934	−1.2%	3	before history	1.34%
ALT	Altimmune, Inc. Healthcare	NEW	2,660,000	NEW	$8,086,400	NEW	1	$2.99	1.28%
NERV	Minerva Neurosciences, Inc. Healthcare	Held	1,419,000	0	$7,875,450	−7.9%	2	$5.74	1.25%
PMN	ProMIS Neurosciences Inc. Healthcare	Held	557,103	0	$7,331,475	+3.6%	2	$14.91	1.16%
OKUR	OnKure Therapeutics, Inc. Healthcare	NEW	1,438,456	NEW	$6,559,359	NEW	1	$4.29	1.04%
		NEW	273,181	NEW	$5,805,096	NEW	1	$23.71	0.92%
RACC	Research Alliance Corp III Financial Services	NEW	500,000	NEW	$5,350,000	NEW	1	$10.42	0.85%
VTVT	vTv Therapeutics Inc. Healthcare	Reduced	85,192	-54,386	$3,207,478	−42.1%	3	before history	0.51%
IMA	ImageneBio, Inc. Healthcare	NEW	282,004	NEW	$1,663,823	NEW	1	$5.65	0.26%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.